{"gene":"RAPGEF4","run_date":"2026-04-28T19:45:45","timeline":{"discoveries":[{"year":2000,"finding":"cAMP-GEFII (RAPGEF4/Epac2) directly binds to Rim (Rab3-interacting molecule) and Rim2, and through this interaction mediates cAMP-induced, Ca2+-dependent exocytosis in a PKA-independent manner, establishing it as a direct cAMP target in the exocytotic machinery.","method":"Co-immunoprecipitation, pulldown, reconstituted exocytosis assay with PKA inhibitor","journal":"Nature cell biology","confidence":"High","confidence_rationale":"Tier 1-2 — reconstituted system plus binding assays, foundational paper with >387 citations","pmids":["11056535"],"is_preprint":false},{"year":2001,"finding":"The cAMP-GEFII–Rim2 pathway is critical for incretin-potentiated insulin secretion in native pancreatic beta-cells, acting via a PKA-independent mechanism that depends on intracellular calcium and cAMP, and mediates both first and second phases of insulin secretion.","method":"Antisense oligodeoxynucleotide knockdown of cAMP-GEFII in isolated pancreatic islets, combined with PKA inhibitor H-89, measuring insulin secretion","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — loss-of-function with defined cellular phenotype, replicated with pharmacological inhibition, >289 citations","pmids":["11598134"],"is_preprint":false},{"year":2001,"finding":"The EPAC2 gene encodes at least three isoforms including a liver-specific form (Epac2C/79 kDa) that lacks the first cAMP-binding domain and the DEP domain but retains GEF activity toward Rap1; gene maps to human chromosome 2q31 with 31+ exons.","method":"cDNA cloning from human liver, primer extension, RT-PCR, in situ hybridization, immunoblot, GEF activity assay","journal":"Genomics","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal methods in single study characterizing gene structure and biochemical activity","pmids":["11707077"],"is_preprint":false},{"year":2002,"finding":"Piccolo, a CAZ protein, binds to cAMP-GEFII and forms Ca2+-dependent homodimers and heterodimers with Rim2, serving as a Ca2+ sensor in the cAMP-GEFII·Rim2·Piccolo complex required for cAMP-induced insulin secretion in pancreatic beta-cells.","method":"Co-immunoprecipitation, pulldown assays, antisense oligodeoxynucleotide knockdown, insulin secretion assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 — binding reconstitution plus functional knockdown with defined phenotype, >166 citations","pmids":["12401793"],"is_preprint":false},{"year":2003,"finding":"Sulfonylurea receptor 1 (SUR1), a subunit of KATP channels, interacts specifically with cAMP-GEFII through its nucleotide-binding fold 1 (NBF1), and this interaction is decreased by high cAMP concentrations; cAMP-GEFII co-localizes with Rim2 at the plasma membrane in insulin-secreting MIN6 cells, and Rim2 and Piccolo directly bind to the alpha1.2 subunit of L-type voltage-dependent Ca2+ channels.","method":"Co-immunoprecipitation, subcellular localization by immunocytochemistry, dominant-negative overexpression","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 — multiple binding assays plus localization and functional overexpression experiments, >142 citations","pmids":["14660679"],"is_preprint":false},{"year":2003,"finding":"cAMP-GEFII mediates GLP-1-stimulated Ca2+ release through ryanodine receptors (RyR) in pancreatic MIN6 beta-cells, leading to mitochondrial ATP synthesis; a dominant-negative form of cAMP-GEFII (G114E, G422D) blocks RyR-mediated mitochondrial [ATP] increases.","method":"Dominant-negative cAMP-GEFII mutant overexpression, ryanodine/xestospongin C pharmacological dissection, mitochondrial Ca2+ and ATP imaging","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 1-2 — dominant-negative mutagenesis with multiple orthogonal measurements, >177 citations","pmids":["12410638"],"is_preprint":false},{"year":2003,"finding":"cAMP-GEFII (Epac2) is required for the PKA-independent component of cAMP-stimulated exocytosis in pancreatic beta-cells, and SUR1 deficiency eliminates this PKA-independent exocytosis by preventing cAMP-stimulated Cl- influx into granules needed for priming.","method":"Antisense oligodeoxynucleotide knockdown, membrane capacitance measurements, SUR1-/- mouse islets, Epac-selective agonist 8CPT-2Me-cAMP","journal":"The Journal of general physiology","confidence":"High","confidence_rationale":"Tier 1-2 — genetic KO plus pharmacological dissection with electrophysiological readout, >212 citations","pmids":["12601083"],"is_preprint":false},{"year":2004,"finding":"SUR1, cAMP-GEFII, and Piccolo can form a multi-protein complex; cAMP (via 8-bromo-cAMP) inhibits cAMP-GEFII–SUR1 interaction but not the cAMP-GEFII–SUR1 interaction in the presence of ATP; Piccolo interacts with the alpha1.2 subunit of VDCC in a Ca2+-independent manner, integrating ATP, cAMP, and Ca2+ signals at a specialized beta-cell domain.","method":"Co-immunoprecipitation with pharmacological treatments (cAMP analogue, ATP)","journal":"Diabetes","confidence":"Medium","confidence_rationale":"Tier 3 — Co-IP with pharmacological manipulation, single lab, extends prior findings","pmids":["15561922"],"is_preprint":false},{"year":2005,"finding":"Epac2/cAMP-GEFII selectively stimulates the linear (ATP-independent, release-ready vesicle) component of Ca2+-dependent exocytosis in mouse pituitary melanotrophs, whereas PKA controls the threshold (ATP-dependent) component; these two pathways are pharmacologically dissociable.","method":"Whole-cell patch-clamp membrane capacitance measurements in pituitary tissue slices, Epac-selective agonist 8-pCPT-2Me-cAMP vs. PKA agonist/inhibitors","journal":"The Journal of physiology","confidence":"Medium","confidence_rationale":"Tier 2 — electrophysiological readout with pharmacological dissection, single lab","pmids":["15994184"],"is_preprint":false},{"year":2007,"finding":"Epac2 (RapGEF4) activation by elevated cAMP (via anthrax edema toxin) induces cytoskeletal changes and inhibits chemotaxis in primary human microvascular endothelial cells through downstream Rap1 activation.","method":"Adenoviral overexpression of activated Epac/Rap1, pharmacological cAMP elevation, chemotaxis assay, cytoskeletal imaging","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — gain-of-function with defined cellular phenotype, single lab","pmids":["17491018"],"is_preprint":false},{"year":2009,"finding":"Activation of Epac2 in rat cortical neurons induces spine shrinkage, increased spine motility, removal of synaptic GluR2/3-containing AMPA receptors, and depression of excitatory transmission; Epac2 interaction with neuroligin promotes membrane recruitment of Epac2 and enhances its GEF activity; autism-associated missense mutations in EPAC2/RAPGEF4 alter basal and neuroligin-stimulated GEF activity, dendritic Rap signaling, synaptic protein distribution and spine morphology.","method":"Pharmacological Epac2 activation, shRNA knockdown, co-immunoprecipitation, GEF activity assay, live imaging, electrophysiology in cultured rat cortical neurons","journal":"Nature neuroscience","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal methods (GEF assay, electrophysiology, imaging, KD, mutagenesis), strong paper >133 citations","pmids":["19734897"],"is_preprint":false},{"year":2009,"finding":"The N-terminal cAMP-binding domain A of Epac2A determines its plasma membrane localization in insulin-secreting MIN6 cells; Epac2B (lacking domain A) localizes primarily to cytoplasm and does not potentiate hormone secretion, whereas addition of a membrane-targeting signal to Epac2B restores secretory function.","method":"Identification of novel splice variant Epac2B in Epac2 KO mouse study, immunocytochemistry, hormone secretion assays in MIN6 cells with WT and mutant Epac2 constructs","journal":"Journal of cellular physiology","confidence":"High","confidence_rationale":"Tier 1-2 — domain deletion/substitution with both localization and functional readouts, Epac2 KO mice","pmids":["19170062"],"is_preprint":false},{"year":2009,"finding":"SNAP-25 interacts with both cAMP-GEFII and Rim2, and is required for cAMP-dependent enhancement of the immediately releasable pool of insulin granules via the PKA-independent cAMP-GEFII pathway; truncation of SNAP-25 C-terminus abolishes cAMP potentiation of rapid exocytosis.","method":"Capacitance measurements, protein binding assays (pulldown), Western blot, overexpression of truncated SNAP-25 and BoNT/A in INS-1 cells","journal":"American journal of physiology. Endocrinology and metabolism","confidence":"Medium","confidence_rationale":"Tier 2 — binding assay plus electrophysiological functional readout, single lab","pmids":["19509185"],"is_preprint":false},{"year":2011,"finding":"RAPGEF4 (Epac2) localizes to the midpiece of equine sperm; activation of RAPGEF3/RAPGEF4 with selective agonist 8pCPT induces acrosomal exocytosis in capacitated stallion sperm and prevents capacitation-dependent membrane hyperpolarization, indicating RAPGEF4 regulates membrane potential and acrosomal exocytosis.","method":"Indirect immunofluorescence, acrosome reaction assay, membrane potential measurements, pharmacological agonist","journal":"Biology of reproduction","confidence":"Medium","confidence_rationale":"Tier 2-3 — localization with functional consequence, pharmacological activation, single lab","pmids":["21471298"],"is_preprint":false},{"year":2012,"finding":"Sulfonylureas activate Epac2 (cAMP-GEFII) to stimulate Rap1 signaling, promoting insulin granule exocytosis in a mechanism distinct from KATP channel closure; gliclazide is unique among sulfonylureas in that it does not activate Epac2, explaining its different secretory profile.","method":"Pharmacological studies comparing sulfonylurea effects on Epac2/Rap1 signaling and insulin secretion; mechanistic review integrating prior biochemical findings","journal":"Diabetes, obesity & metabolism","confidence":"Medium","confidence_rationale":"Tier 3 — pharmacological evidence with mechanistic interpretation; supported by prior mechanistic work","pmids":["22118705"],"is_preprint":false},{"year":2013,"finding":"GLP-1R activation promotes Epac2 (RAPGEF4) translocation to the membrane in cardiomyocytes, and Epac2 deficiency eliminates GLP-1R-dependent stimulation of atrial natriuretic peptide (ANP) secretion, placing Epac2 as a required mediator in the gut-heart GLP-1R–ANP axis regulating blood pressure.","method":"Genetic KO of Epac2 (Rapgef4-/-) mice, live cell imaging of Epac2 translocation, ANP secretion assays, blood pressure measurement, aortic ring relaxation assay","journal":"Nature medicine","confidence":"High","confidence_rationale":"Tier 1-2 — genetic KO with specific phenotypic readout plus live imaging of translocation, highly cited >410 citations","pmids":["23542788"],"is_preprint":false},{"year":2013,"finding":"Rapgef4-dependent signaling downstream of Gnas/cAMP elevation regulates proximal tubular exo- and endocytosis in Xenopus pronephros and in human proximal tubular cells; a Rapgef4-specific agonist mimics cholera toxin effects on albumin uptake and secretion.","method":"Antisense morpholino knockdown in Xenopus, pharmacological agonist treatment, FITC-albumin uptake/secretion assay in human proximal tubular cell line","journal":"Developmental biology","confidence":"Medium","confidence_rationale":"Tier 2 — morpholino KD with phenotypic readout plus pharmacological agonist confirmation in human cells","pmids":["23352791"],"is_preprint":false},{"year":2014,"finding":"EPAC2 regulates calreticulin (CALR) expression in human endometrial glandular cells, and the EPAC2–CALR signaling axis is required for cAMP-stimulated expression of LIF and COX2/PTGS2 and prostaglandin E2 secretion; EPAC2 or CALR knockdown increases cellular senescence markers.","method":"siRNA knockdown of EPAC2 and CALR in EM1 cells, EPAC-selective vs. PKA-selective cAMP analogues, gene expression and PGE2 secretion assays, senescence assay","journal":"Journal of molecular endocrinology","confidence":"Medium","confidence_rationale":"Tier 2 — siRNA KD with pharmacological dissection and multiple functional readouts, single lab","pmids":["25378661"],"is_preprint":false},{"year":2015,"finding":"Crystallographic analyses reveal that activation of Epac2 by cAMP is accompanied by dynamic structural changes; Epac2 functions as a direct cAMP sensor that activates Rap GTPases via its GEF domain, with distinct structural domains (N-terminal cAMP-binding domain A, DEP domain, and catalytic GEF domain) each contributing to regulation and localization.","method":"Crystallographic structural analysis, domain function review integrating published structural and biochemical data","journal":"Gene","confidence":"High","confidence_rationale":"Tier 1 — crystallographic structural data plus integration of biochemical domain function studies","pmids":["26390815"],"is_preprint":false},{"year":2015,"finding":"Epac2/Rapgef4 (via PACAP-PAC1 receptor-AC6 pathway) acts as a cAMP sensor downstream of a specific adenylate cyclase isoform (AC6 but not AC7) in neuroendocrine PC12 cells, phosphorylating p38 as a downstream target; this signaling is disrupted by membrane cholesterol depletion.","method":"Lentiviral shRNA knockdown of AC6 or AC7, PACAP stimulation, phospho-p38 readout, methyl-β-cyclodextrin cholesterol depletion","journal":"Molecular pharmacology","confidence":"Medium","confidence_rationale":"Tier 2 — specific AC isoform KD with defined downstream readout, single lab","pmids":["25769305"],"is_preprint":false},{"year":2016,"finding":"Epac2 knockout (Epac2-/-) mice exhibit anxiety, depression, and hippocampal neurogenesis defects; fluoxetine (SSRI/Prozac) treatment rescues open-field behavior and hippocampal cell proliferation in Epac2-/- mice, implicating Epac2 in serotonin/cAMP-mediated mood regulation and neurogenesis.","method":"Genetic KO mouse model, behavioral tests, hippocampal cell proliferation assays, SSRI pharmacological rescue","journal":"Translational psychiatry","confidence":"Medium","confidence_rationale":"Tier 2 — genetic KO with multiple behavioral and cellular phenotypic readouts, single lab","pmids":["27598965"],"is_preprint":false},{"year":2019,"finding":"Epac2 (Rap-GEF4) controls fusion pore expansion during insulin exocytosis by acutely recruiting two pore-restricting proteins, amisyn and dynamin-1, to the exocytosis site; cAMP elevation restricts and slows fusion pore expansion and peptide release in a manner dependent on Epac2 (lost in Epac2-/- mice and with pharmacological Epac2 inactivation); GLP-1R agonists and sulfonylureas activate this pathway.","method":"Live-cell TIRF imaging, Epac2-/- mice, pharmacological Epac2 inhibition/activation, Epac2 overexpression, amperometry/capacitance measurements","journal":"eLife","confidence":"High","confidence_rationale":"Tier 1-2 — genetic KO plus pharmacology plus live imaging plus overexpression with multiple orthogonal functional readouts","pmids":["31099751"],"is_preprint":false},{"year":2021,"finding":"RAPGEF4/EPAC2 mediates exendin-4 (GLP-1R agonist)-stimulated autophagic flux in pancreatic beta-cells through a Ca2+-PPP3/calcineurin-TFEB axis, independent of AMPK and mTOR; EPAC2 knockdown abolishes exendin-4-induced autophagy and cell survival, and TFEB overexpression mimics EPAC2-dependent cell protection.","method":"siRNA knockdown of RAPGEF4, chemical inhibitors, TFEB overexpression, autophagic flux assays, db/db mouse in vivo treatment","journal":"Autophagy","confidence":"High","confidence_rationale":"Tier 2 — siRNA KD, pharmacological dissection, genetic rescue, and in vivo validation with multiple orthogonal readouts","pmids":["34338148"],"is_preprint":false},{"year":2021,"finding":"EPAC2 overexpression inhibits tubulogenesis and endothelial cell migration in Matrigel assays, while EPAC2 knockdown enhances tube formation and cell migration with elongated morphology and filopodia-like protrusions; RAPGEF4 expression increases during Matrigel-driven tubulogenesis, acting as a negative regulator of angiogenic network formation.","method":"Microarray, EPAC2 overexpression and siRNA knockdown in HMVECs, Matrigel tube formation assay, migration assay, morphology imaging","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 — gain- and loss-of-function with defined cellular phenotypes, single lab","pmids":["34593918"],"is_preprint":false},{"year":2025,"finding":"RAPGEF4 is required for electrophysiological maturation of prefrontal cortex neurons (resting membrane potential and inward sodium current) in rhesus macaque and human; CHD8 knockdown impairs neuronal maturation by downregulating RAPGEF4, and restoring RAPGEF4 expression rescues electrophysiological maturation in CHD8-deficient neurons.","method":"Patch-seq, single-nucleus multiomic analysis, shRNA knockdown of CHD8, RAPGEF4 rescue overexpression in organotypic slices from macaque and human, electrophysiological recordings","journal":"Neuron","confidence":"High","confidence_rationale":"Tier 2 — KD plus genetic rescue with defined electrophysiological phenotype in multiple model systems (macaque and human)","pmids":["40398411"],"is_preprint":false},{"year":2025,"finding":"Hepatic EPAC2 (RAPGEF4) knockdown does not affect hepatic amino acid catabolism gene expression, plasma amino acid levels, or pancreatic alpha-cell hyperplasia, distinguishing EPAC2 from the hepatic GCGR-GNAS-PKA pathway that mediates these effects in the liver-alpha-cell loop.","method":"In vivo hepatic knockdown of GCGR, GNAS, PKA, and EPAC2 in mice; measurement of amino acid catabolism genes, plasma amino acids, alpha-cell mass","journal":"Diabetes","confidence":"Medium","confidence_rationale":"Tier 2 — genetic epistasis by specific knockdown, comparison of multiple pathway components, defined phenotypic readouts","pmids":["40095004"],"is_preprint":false},{"year":2025,"finding":"Rapgef4 (Epac2) is among 184 genes concordantly dysregulated in both excitatory and inhibitory cortical neurons of Fmr1 KO (Fragile X) mice, is an FMRP target and ASD risk gene; pharmacological antagonism of EPAC2 restores cortical circuit function and ameliorates sensory behavioral phenotypes in Fmr1 KO mice.","method":"Cell-type specific mRNA sequencing (TRAP-seq), EPAC2 antagonist systemic administration, electrophysiological circuit recordings, behavioral assays in Fmr1 KO mice","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 — transcriptomics plus pharmacological intervention with circuit and behavioral phenotypic readouts; preprint","pmids":["bio_10.1101_2025.04.21.649817"],"is_preprint":true}],"current_model":"RAPGEF4 (Epac2/cAMP-GEFII) is a direct cAMP sensor that, upon cAMP binding to its N-terminal regulatory domain, undergoes conformational activation and translocates to the plasma membrane where it acts as a guanine nucleotide exchange factor (GEF) for the small GTPase Rap1/Rap2; it forms multi-protein complexes with Rim2, Piccolo, SUR1, SNAP-25, and L-type Ca2+ channels to mediate PKA-independent, Ca2+-dependent exocytosis of insulin and other hormones, controls fusion pore expansion by recruiting amisyn and dynamin-1, regulates synaptic spine remodeling and AMPA receptor trafficking via neuroligin-stimulated GEF activity, drives autophagy in beta-cells through a Ca2+-calcineurin-TFEB axis, and is required for electrophysiological maturation of prefrontal cortex neurons."},"narrative":{"teleology":[{"year":2000,"claim":"Identification of RAPGEF4 as a direct cAMP effector in exocytosis resolved how cAMP potentiates secretion independently of PKA, establishing the Epac2–Rim2 interaction as the molecular link between cAMP sensing and the exocytotic machinery.","evidence":"Co-immunoprecipitation, pulldown, and reconstituted exocytosis assay with PKA inhibitor","pmids":["11056535"],"confidence":"High","gaps":["Structural basis of Epac2–Rim2 interaction not resolved","Relative contribution of Epac2 versus PKA in vivo not quantified"]},{"year":2001,"claim":"Demonstration that the Epac2–Rim2 pathway is essential for incretin-potentiated insulin secretion in native beta-cells moved the mechanism from reconstituted systems to physiological insulin release, answering whether this pathway operates in primary endocrine tissue.","evidence":"Antisense knockdown in isolated islets with PKA inhibitor H-89, insulin secretion measurement","pmids":["11598134"],"confidence":"High","gaps":["No genetic knockout confirmation at this stage","Downstream effectors beyond Rim2 unknown"]},{"year":2002,"claim":"Discovery that Piccolo serves as a Ca²⁺ sensor within the cAMP-GEFII·Rim2·Piccolo complex explained how calcium dependence is integrated into the PKA-independent exocytotic pathway.","evidence":"Co-immunoprecipitation, pulldown, antisense knockdown, insulin secretion assay in beta-cells","pmids":["12401793"],"confidence":"High","gaps":["Stoichiometry and assembly order of the ternary complex unknown","Whether other Ca²⁺ sensors substitute in non-beta-cell contexts untested"]},{"year":2003,"claim":"Mapping the interaction of Epac2 with SUR1 (via NBF1) and the connection of Rim2/Piccolo to L-type Ca²⁺ channels revealed a multi-protein signaling hub integrating KATP channel status, cAMP, and Ca²⁺ influx at the beta-cell plasma membrane.","evidence":"Co-immunoprecipitation, immunocytochemistry, dominant-negative overexpression in MIN6 cells; SUR1-/- mouse electrophysiology","pmids":["14660679","12601083"],"confidence":"High","gaps":["Direct structural interface between SUR1 and Epac2 unresolved","Whether SUR1 interaction is permissive or instructive for GEF activity unclear"]},{"year":2003,"claim":"Showing that Epac2 mediates GLP-1-stimulated Ca²⁺ release through ryanodine receptors linked Epac2 to intracellular Ca²⁺ store mobilization and mitochondrial ATP production, broadening its role beyond plasma membrane exocytosis.","evidence":"Dominant-negative Epac2 mutant, pharmacological dissection with ryanodine/xestospongin C, mitochondrial Ca²⁺/ATP imaging in MIN6 cells","pmids":["12410638"],"confidence":"High","gaps":["Whether Epac2 directly activates RyR or acts through Rap-dependent intermediaries unknown"]},{"year":2009,"claim":"Discovery that Epac2 interacts with neuroligin and regulates spine morphology, AMPA receptor trafficking, and excitatory synaptic transmission established a neuronal function for Epac2 beyond endocrine exocytosis, and linked autism-associated RAPGEF4 missense variants to altered GEF activity and dendritic signaling.","evidence":"Pharmacological activation, shRNA knockdown, co-immunoprecipitation, GEF assay, electrophysiology, and live imaging in cultured rat cortical neurons","pmids":["19734897"],"confidence":"High","gaps":["In vivo validation of autism-associated variants lacking","Downstream Rap effectors mediating spine remodeling not identified"]},{"year":2009,"claim":"Defining that the N-terminal cAMP-binding domain A governs Epac2 plasma membrane localization and is required for secretory potentiation clarified why the Epac2B splice variant (lacking domain A) is functionally impaired, resolving isoform-specific differences in secretory function.","evidence":"Epac2 KO mouse, domain deletion/membrane-targeting rescue constructs, immunocytochemistry and secretion assays in MIN6 cells","pmids":["19170062"],"confidence":"High","gaps":["Binding partner for domain A at the membrane not identified","Tissue-specific expression patterns of Epac2A vs Epac2B incompletely mapped"]},{"year":2013,"claim":"Genetic knockout of Epac2 in mice eliminated GLP-1R-dependent ANP secretion from cardiomyocytes, establishing Epac2 as an essential mediator in a gut–heart endocrine axis controlling blood pressure.","evidence":"Rapgef4-/- mice, live-cell imaging of Epac2 translocation, ANP secretion assays, blood pressure measurement, aortic ring relaxation","pmids":["23542788"],"confidence":"High","gaps":["Whether Epac2 acts through Rap1 or an alternative effector in cardiomyocytes unknown","Human cardiovascular relevance not directly tested"]},{"year":2015,"claim":"Crystallographic resolution of Epac2 structural dynamics upon cAMP binding provided a molecular framework for how autoinhibition is relieved and the GEF domain becomes catalytically competent, answering how cAMP binding is mechanically transduced to Rap activation.","evidence":"Crystallographic structural analysis integrated with biochemical domain studies","pmids":["26390815"],"confidence":"High","gaps":["Full-length Epac2 structure in complex with Rap and membrane lipids not determined","Allosteric coupling between the two cAMP-binding domains structurally unresolved"]},{"year":2019,"claim":"Demonstration that Epac2 controls fusion pore expansion by recruiting amisyn and dynamin-1 resolved the long-standing question of how cAMP modulates the kinetics (not just competence) of exocytosis, shifting understanding from granule priming to pore regulation.","evidence":"TIRF imaging, Epac2-/- mice, pharmacological inhibition/activation, amperometry/capacitance in beta-cells","pmids":["31099751"],"confidence":"High","gaps":["Direct GEF-dependent versus GEF-independent mechanism for amisyn/dynamin-1 recruitment not distinguished","Whether this pore regulation mechanism operates in neurons unknown"]},{"year":2021,"claim":"Identification of Epac2 as a mediator of GLP-1R agonist-stimulated autophagy via Ca²⁺–calcineurin–TFEB revealed an entirely new cellular process controlled by Epac2 in beta-cells, distinct from its exocytotic role, answering how incretin signaling promotes beta-cell survival.","evidence":"siRNA knockdown, chemical inhibitors, TFEB overexpression rescue, autophagic flux assays, db/db mouse in vivo treatment","pmids":["34338148"],"confidence":"High","gaps":["Whether Epac2-driven autophagy operates in non-beta-cell tissues untested","Specific Rap effector downstream of Epac2 in autophagy induction unidentified"]},{"year":2025,"claim":"Rescue of electrophysiological maturation deficits in CHD8-deficient prefrontal cortex neurons by RAPGEF4 re-expression established Epac2 as a critical downstream target of CHD8 for neuronal functional maturation, connecting an autism risk chromatin remodeler to cAMP–Rap signaling.","evidence":"Patch-seq, single-nucleus multiomic analysis, shRNA knockdown of CHD8, RAPGEF4 rescue overexpression in organotypic macaque and human cortical slices","pmids":["40398411"],"confidence":"High","gaps":["Whether CHD8 directly regulates RAPGEF4 transcription or acts indirectly unresolved","Downstream Rap effectors mediating neuronal maturation not identified"]},{"year":null,"claim":"Key unresolved questions include the identity of the Rap effectors mediating Epac2-dependent spine remodeling and neuronal maturation, whether fusion pore regulation by amisyn/dynamin-1 recruitment is GEF-dependent, the full-length membrane-associated Epac2 structure, and whether Epac2-driven autophagy generalizes beyond beta-cells.","evidence":"","pmids":[],"confidence":"Medium","gaps":["Rap effectors downstream of Epac2 in neuronal contexts unidentified","Structural basis of Epac2 interaction with neuroligin and amisyn unknown","In vivo validation of autism-associated RAPGEF4 variants in animal models lacking"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[0,2,10,18]},{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[0,5,18,19]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[4,11,15]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[11]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,5,9,10,15,19]},{"term_id":"R-HSA-9612973","term_label":"Autophagy","supporting_discovery_ids":[22]},{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[10,20,24]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[1,6,21]}],"complexes":["Epac2–Rim2–Piccolo","Epac2–SUR1–Rim2"],"partners":["RIMS2","PCLO","ABCC8","SNAP25","NLGN1","AMISYN","DNM1","CHD8"],"other_free_text":[]},"mechanistic_narrative":"RAPGEF4 (Epac2/cAMP-GEFII) is a cAMP-activated guanine nucleotide exchange factor for Rap1/Rap2 GTPases that functions as a PKA-independent cAMP sensor mediating regulated exocytosis, synaptic remodeling, autophagy, and neuronal maturation. Upon cAMP binding to its N-terminal regulatory domain, Epac2 undergoes conformational activation and translocates to the plasma membrane, where it assembles multi-protein complexes with Rim2, Piccolo, SUR1, SNAP-25, and L-type Ca²⁺ channels to drive Ca²⁺-dependent insulin granule exocytosis and control fusion pore dynamics through recruitment of amisyn and dynamin-1 [PMID:11056535, PMID:12401793, PMID:14660679, PMID:31099751]. In neurons, Epac2 interacts with neuroligin to regulate dendritic spine morphology, AMPA receptor trafficking, and excitatory transmission, and is required for electrophysiological maturation of prefrontal cortex neurons downstream of CHD8 [PMID:19734897, PMID:40398411]. Epac2 also mediates GLP-1 receptor-stimulated atrial natriuretic peptide secretion in cardiomyocytes and drives protective autophagy in pancreatic beta-cells through a Ca²⁺–calcineurin–TFEB axis [PMID:23542788, PMID:34338148]."},"prefetch_data":{"uniprot":{"accession":"Q8WZA2","full_name":"Rap guanine nucleotide exchange factor 4","aliases":["Exchange factor directly activated by cAMP 2","Exchange protein directly activated by cAMP 2","EPAC 2","cAMP-regulated guanine nucleotide exchange factor II","cAMP-GEFII"],"length_aa":1011,"mass_kda":115.5,"function":"Guanine nucleotide exchange factor (GEF) for RAP1A, RAP1B and RAP2A small GTPases that is activated by binding cAMP. Does not seem to activate RAB3A. Involved in cAMP-dependent, PKA-independent exocytosis through interaction with RIMS2 (By similarity)","subcellular_location":"Cytoplasm; Membrane","url":"https://www.uniprot.org/uniprotkb/Q8WZA2/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/RAPGEF4","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/RAPGEF4","total_profiled":1310},"omim":[{"mim_id":"606058","title":"RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR; RAPGEF4","url":"https://www.omim.org/entry/606058"},{"mim_id":"606057","title":"RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 3; RAPGEF3","url":"https://www.omim.org/entry/606057"},{"mim_id":"209850","title":"AUTISM","url":"https://www.omim.org/entry/209850"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Focal adhesion sites","reliability":"Approved"},{"location":"Plasma membrane","reliability":"Additional"},{"location":"Basal body","reliability":"Additional"},{"location":"Cytosol","reliability":"Additional"},{"location":"Mid piece","reliability":"Additional"}],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"brain","ntpm":272.2}],"url":"https://www.proteinatlas.org/search/RAPGEF4"},"hgnc":{"alias_symbol":["cAMP-GEFII","CGEF2"],"prev_symbol":[]},"alphafold":{"accession":"Q8WZA2","domains":[{"cath_id":"2.60.120.10","chopping":"7-154","consensus_level":"high","plddt":87.7264,"start":7,"end":154},{"cath_id":"1.10.10.10","chopping":"200-322","consensus_level":"high","plddt":93.0767,"start":200,"end":322},{"cath_id":"2.60.120.10","chopping":"343-456","consensus_level":"medium","plddt":87.0005,"start":343,"end":456},{"cath_id":"1.20.870.10","chopping":"470-481_497-639","consensus_level":"medium","plddt":88.1908,"start":470,"end":639},{"cath_id":"3.10.20.90","chopping":"646-756","consensus_level":"medium","plddt":89.4032,"start":646,"end":756},{"cath_id":"1.10.840.10","chopping":"763-1005","consensus_level":"high","plddt":93.3818,"start":763,"end":1005}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8WZA2","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q8WZA2-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q8WZA2-F1-predicted_aligned_error_v6.png","plddt_mean":87.0},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=RAPGEF4","jax_strain_url":"https://www.jax.org/strain/search?query=RAPGEF4"},"sequence":{"accession":"Q8WZA2","fasta_url":"https://rest.uniprot.org/uniprotkb/Q8WZA2.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q8WZA2/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8WZA2"}},"corpus_meta":[{"pmid":"23542788","id":"PMC_23542788","title":"GLP-1 receptor activation and Epac2 link atrial natriuretic peptide secretion to control of blood pressure.","date":"2013","source":"Nature medicine","url":"https://pubmed.ncbi.nlm.nih.gov/23542788","citation_count":410,"is_preprint":false},{"pmid":"11056535","id":"PMC_11056535","title":"cAMP-GEFII is a direct target of cAMP in regulated exocytosis.","date":"2000","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/11056535","citation_count":387,"is_preprint":false},{"pmid":"11598134","id":"PMC_11598134","title":"Critical role of cAMP-GEFII--Rim2 complex in incretin-potentiated insulin secretion.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11598134","citation_count":289,"is_preprint":false},{"pmid":"12601083","id":"PMC_12601083","title":"SUR1 regulates PKA-independent cAMP-induced granule priming in mouse pancreatic B-cells.","date":"2003","source":"The Journal of general physiology","url":"https://pubmed.ncbi.nlm.nih.gov/12601083","citation_count":212,"is_preprint":false},{"pmid":"12410638","id":"PMC_12410638","title":"Glucagon-like peptide-1 mobilizes intracellular Ca2+ and stimulates mitochondrial ATP synthesis in pancreatic MIN6 beta-cells.","date":"2003","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/12410638","citation_count":177,"is_preprint":false},{"pmid":"12401793","id":"PMC_12401793","title":"Piccolo, a Ca2+ sensor in pancreatic beta-cells. Involvement of cAMP-GEFII.Rim2. Piccolo complex in cAMP-dependent exocytosis.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12401793","citation_count":166,"is_preprint":false},{"pmid":"14660679","id":"PMC_14660679","title":"Interaction of ATP sensor, cAMP sensor, Ca2+ sensor, and voltage-dependent Ca2+ channel in insulin granule exocytosis.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14660679","citation_count":142,"is_preprint":false},{"pmid":"19734897","id":"PMC_19734897","title":"Epac2 induces synapse remodeling and depression and its disease-associated forms alter spines.","date":"2009","source":"Nature neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/19734897","citation_count":133,"is_preprint":false},{"pmid":"14593429","id":"PMC_14593429","title":"Screening of nine candidate genes for autism on chromosome 2q reveals rare nonsynonymous variants in the cAMP-GEFII gene.","date":"2003","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/14593429","citation_count":96,"is_preprint":false},{"pmid":"26295306","id":"PMC_26295306","title":"Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells.","date":"2015","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/26295306","citation_count":87,"is_preprint":false},{"pmid":"19170062","id":"PMC_19170062","title":"Critical role of the N-terminal cyclic AMP-binding domain of Epac2 in its subcellular localization and function.","date":"2009","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/19170062","citation_count":81,"is_preprint":false},{"pmid":"26474971","id":"PMC_26474971","title":"A genome-wide approach to link genotype to clinical outcome by utilizing next generation sequencing and gene chip data of 6,697 breast cancer patients.","date":"2015","source":"Genome medicine","url":"https://pubmed.ncbi.nlm.nih.gov/26474971","citation_count":70,"is_preprint":false},{"pmid":"11707077","id":"PMC_11707077","title":"Characterization of the gene EPAC2: structure, chromosomal localization, tissue expression, and identification of the liver-specific isoform.","date":"2001","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/11707077","citation_count":52,"is_preprint":false},{"pmid":"17491018","id":"PMC_17491018","title":"Anthrax edema toxin inhibits endothelial cell chemotaxis via Epac and Rap1.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17491018","citation_count":52,"is_preprint":false},{"pmid":"29986310","id":"PMC_29986310","title":"Folic acid supplementation alters the DNA methylation profile and improves insulin resistance in high-fat-diet-fed mice.","date":"2018","source":"The Journal of nutritional biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/29986310","citation_count":51,"is_preprint":false},{"pmid":"15561922","id":"PMC_15561922","title":"Integration of ATP, cAMP, and Ca2+ signals in insulin granule exocytosis.","date":"2004","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/15561922","citation_count":50,"is_preprint":false},{"pmid":"15994184","id":"PMC_15994184","title":"cAMP increases Ca2+-dependent exocytosis through both PKA and Epac2 in mouse melanotrophs from pituitary tissue slices.","date":"2005","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/15994184","citation_count":50,"is_preprint":false},{"pmid":"22118705","id":"PMC_22118705","title":"Treating diabetes today: a matter of selectivity of sulphonylureas.","date":"2012","source":"Diabetes, obesity & metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/22118705","citation_count":48,"is_preprint":false},{"pmid":"26390815","id":"PMC_26390815","title":"Structure and functional roles of Epac2 (Rapgef4).","date":"2015","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/26390815","citation_count":47,"is_preprint":false},{"pmid":"31099751","id":"PMC_31099751","title":"Fusion pore regulation by cAMP/Epac2 controls cargo release during insulin exocytosis.","date":"2019","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/31099751","citation_count":38,"is_preprint":false},{"pmid":"27598965","id":"PMC_27598965","title":"Anxiety and depression with neurogenesis defects in exchange protein directly activated by cAMP 2-deficient mice are ameliorated by a selective serotonin reuptake inhibitor, Prozac.","date":"2016","source":"Translational psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/27598965","citation_count":38,"is_preprint":false},{"pmid":"24006282","id":"PMC_24006282","title":"Signaling in sperm: toward a molecular understanding of the acquisition of sperm motility in the mouse epididymis.","date":"2013","source":"Biology of reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/24006282","citation_count":38,"is_preprint":false},{"pmid":"19509185","id":"PMC_19509185","title":"Truncation of SNAP-25 reduces the stimulatory action of cAMP on rapid exocytosis in insulin-secreting cells.","date":"2009","source":"American journal of physiology. Endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/19509185","citation_count":37,"is_preprint":false},{"pmid":"32800727","id":"PMC_32800727","title":"Two-stage Study of Familial Prostate Cancer by Whole-exome Sequencing and Custom Capture Identifies 10 Novel Genes Associated with the Risk of Prostate Cancer.","date":"2020","source":"European urology","url":"https://pubmed.ncbi.nlm.nih.gov/32800727","citation_count":37,"is_preprint":false},{"pmid":"25813215","id":"PMC_25813215","title":"Orexin A regulates plasma insulin and leptin levels in a time-dependent manner following a glucose load in mice.","date":"2015","source":"Diabetologia","url":"https://pubmed.ncbi.nlm.nih.gov/25813215","citation_count":35,"is_preprint":false},{"pmid":"34338148","id":"PMC_34338148","title":"Exendin-4 stimulates autophagy in pancreatic β-cells via the RAPGEF/EPAC-Ca2+-PPP3/calcineurin-TFEB axis.","date":"2021","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/34338148","citation_count":32,"is_preprint":false},{"pmid":"21471298","id":"PMC_21471298","title":"Guanine-nucleotide exchange factors (RAPGEF3/RAPGEF4) induce sperm membrane depolarization and acrosomal exocytosis in capacitated stallion sperm.","date":"2011","source":"Biology of reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/21471298","citation_count":31,"is_preprint":false},{"pmid":"25378661","id":"PMC_25378661","title":"EPAC2-mediated calreticulin regulates LIF and COX2 expression in human endometrial glandular cells.","date":"2014","source":"Journal of molecular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/25378661","citation_count":23,"is_preprint":false},{"pmid":"37800580","id":"PMC_37800580","title":"Function of m5C RNA methyltransferase NOP2 in high-grade serous ovarian cancer.","date":"2023","source":"Cancer biology & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/37800580","citation_count":21,"is_preprint":false},{"pmid":"27379015","id":"PMC_27379015","title":"Role of EPAC in cAMP-Mediated Actions in Adrenocortical Cells.","date":"2016","source":"Frontiers in endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/27379015","citation_count":17,"is_preprint":false},{"pmid":"25769305","id":"PMC_25769305","title":"Cyclic Adenosine 3',5'-Monophosphate Elevation and Biological Signaling through a Secretin Family Gs-Coupled G Protein-Coupled Receptor Are Restricted to a Single Adenylate Cyclase Isoform.","date":"2015","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/25769305","citation_count":11,"is_preprint":false},{"pmid":"40398411","id":"PMC_40398411","title":"Multimodal analyses reveal genes driving electrophysiological maturation of neurons in the primate prefrontal cortex.","date":"2025","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/40398411","citation_count":9,"is_preprint":false},{"pmid":"32395202","id":"PMC_32395202","title":"EPAC2: A new and promising protein for glioma pathogenesis and therapy.","date":"2020","source":"Oncology reviews","url":"https://pubmed.ncbi.nlm.nih.gov/32395202","citation_count":8,"is_preprint":false},{"pmid":"35834616","id":"PMC_35834616","title":"EPAC Regulates Melanoma Growth by Stimulating mTORC1 Signaling and Loss of EPAC Signaling Dependence Correlates with Melanoma Progression.","date":"2022","source":"Molecular cancer research : MCR","url":"https://pubmed.ncbi.nlm.nih.gov/35834616","citation_count":7,"is_preprint":false},{"pmid":"23352791","id":"PMC_23352791","title":"Regulation of G-protein signaling via Gnas is required to regulate proximal tubular growth in the Xenopus pronephros.","date":"2013","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/23352791","citation_count":6,"is_preprint":false},{"pmid":"20659433","id":"PMC_20659433","title":"Over-expression of the DCLK gene transcript CARP decreases CA3/CA1 network excitability.","date":"2010","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/20659433","citation_count":6,"is_preprint":false},{"pmid":"34516037","id":"PMC_34516037","title":"Investigation of Diagnostic Biomarkers for Osteoporosis Based on Differentially Expressed Gene Profile with QCT and mDixon-Quant Techniques.","date":"2021","source":"Orthopaedic surgery","url":"https://pubmed.ncbi.nlm.nih.gov/34516037","citation_count":5,"is_preprint":false},{"pmid":"34609028","id":"PMC_34609028","title":"Gene polymorphisms of insulin secretion signaling pathway associated with clopidogrel resistance in Han Chinese population.","date":"2021","source":"Journal of clinical laboratory analysis","url":"https://pubmed.ncbi.nlm.nih.gov/34609028","citation_count":5,"is_preprint":false},{"pmid":"16412482","id":"PMC_16412482","title":"Depolarization and Ca(2+) down regulate CB1 receptors and CB1-mediated signaling in cerebellar granule neurons.","date":"2006","source":"Neuropharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/16412482","citation_count":5,"is_preprint":false},{"pmid":"35567499","id":"PMC_35567499","title":"Deciphering complex rearrangements at the breakpoint of an apparently balanced reciprocal translocation t(4:18)(q31;q11.2)dn and at a cryptic deletion: Further evidence of TLL1 as a causative gene for atrial septal defect.","date":"2022","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/35567499","citation_count":4,"is_preprint":false},{"pmid":"37398253","id":"PMC_37398253","title":"Multimodal analyses reveal genes driving electrophysiological maturation of neurons in the primate prefrontal cortex.","date":"2024","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/37398253","citation_count":3,"is_preprint":false},{"pmid":"34593918","id":"PMC_34593918","title":"EPAC2 acts as a negative regulator in Matrigel-driven tubulogenesis of human microvascular endothelial cells.","date":"2021","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/34593918","citation_count":3,"is_preprint":false},{"pmid":"40095004","id":"PMC_40095004","title":"Hepatic PKA Mediates Liver and Pancreatic α-Cell Cross Talk.","date":"2025","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/40095004","citation_count":2,"is_preprint":false},{"pmid":"40025369","id":"PMC_40025369","title":"Sex-specific molecular drivers of cardiac fibrosis in aging hearts.","date":"2025","source":"GeroScience","url":"https://pubmed.ncbi.nlm.nih.gov/40025369","citation_count":2,"is_preprint":false},{"pmid":"40170064","id":"PMC_40170064","title":"Downregulation of FASN in granulosa cells and its impact on ovulatory dysfunction in PCOS.","date":"2025","source":"Journal of ovarian research","url":"https://pubmed.ncbi.nlm.nih.gov/40170064","citation_count":1,"is_preprint":false},{"pmid":"41311249","id":"PMC_41311249","title":"Breast Cancer-Secreted DPP3 Promotes Lung Metastasis by Remodelling the Vascular Niche in Lung via the Rap1 Signalling Pathway.","date":"2025","source":"Journal of extracellular vesicles","url":"https://pubmed.ncbi.nlm.nih.gov/41311249","citation_count":1,"is_preprint":false},{"pmid":"32905835","id":"PMC_32905835","title":"The Epac2 coding gene (RAPGEF4) rs3769219 polymorphism is associated with protection against major depressive disorder in the Chinese Han population.","date":"2020","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/32905835","citation_count":0,"is_preprint":false},{"pmid":"41123461","id":"PMC_41123461","title":"Analysis of copy number variations and selection signatures using whole-genome sequencing data from 16 Chinese duck breeds.","date":"2025","source":"British poultry science","url":"https://pubmed.ncbi.nlm.nih.gov/41123461","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.04.21.649817","title":"Translatome profiling reveals opposing alterations in inhibitory and excitatory neurons of Fragile X mice and identifies EPAC2 as a therapeutic target","date":"2025-04-24","source":"bioRxiv","url":"https://doi.org/10.1101/2025.04.21.649817","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":26701,"output_tokens":6582,"usd":0.089416},"stage2":{"model":"claude-opus-4-6","input_tokens":10223,"output_tokens":3315,"usd":0.200985},"total_usd":0.290401,"stage1_batch_id":"msgbatch_01SUR8NDzVrNmyszWyJeCct7","stage2_batch_id":"msgbatch_01G7Yfutko3cDWzejrwH5AMx","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2000,\n      \"finding\": \"cAMP-GEFII (RAPGEF4/Epac2) directly binds to Rim (Rab3-interacting molecule) and Rim2, and through this interaction mediates cAMP-induced, Ca2+-dependent exocytosis in a PKA-independent manner, establishing it as a direct cAMP target in the exocytotic machinery.\",\n      \"method\": \"Co-immunoprecipitation, pulldown, reconstituted exocytosis assay with PKA inhibitor\",\n      \"journal\": \"Nature cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — reconstituted system plus binding assays, foundational paper with >387 citations\",\n      \"pmids\": [\"11056535\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"The cAMP-GEFII–Rim2 pathway is critical for incretin-potentiated insulin secretion in native pancreatic beta-cells, acting via a PKA-independent mechanism that depends on intracellular calcium and cAMP, and mediates both first and second phases of insulin secretion.\",\n      \"method\": \"Antisense oligodeoxynucleotide knockdown of cAMP-GEFII in isolated pancreatic islets, combined with PKA inhibitor H-89, measuring insulin secretion\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — loss-of-function with defined cellular phenotype, replicated with pharmacological inhibition, >289 citations\",\n      \"pmids\": [\"11598134\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"The EPAC2 gene encodes at least three isoforms including a liver-specific form (Epac2C/79 kDa) that lacks the first cAMP-binding domain and the DEP domain but retains GEF activity toward Rap1; gene maps to human chromosome 2q31 with 31+ exons.\",\n      \"method\": \"cDNA cloning from human liver, primer extension, RT-PCR, in situ hybridization, immunoblot, GEF activity assay\",\n      \"journal\": \"Genomics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods in single study characterizing gene structure and biochemical activity\",\n      \"pmids\": [\"11707077\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Piccolo, a CAZ protein, binds to cAMP-GEFII and forms Ca2+-dependent homodimers and heterodimers with Rim2, serving as a Ca2+ sensor in the cAMP-GEFII·Rim2·Piccolo complex required for cAMP-induced insulin secretion in pancreatic beta-cells.\",\n      \"method\": \"Co-immunoprecipitation, pulldown assays, antisense oligodeoxynucleotide knockdown, insulin secretion assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — binding reconstitution plus functional knockdown with defined phenotype, >166 citations\",\n      \"pmids\": [\"12401793\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Sulfonylurea receptor 1 (SUR1), a subunit of KATP channels, interacts specifically with cAMP-GEFII through its nucleotide-binding fold 1 (NBF1), and this interaction is decreased by high cAMP concentrations; cAMP-GEFII co-localizes with Rim2 at the plasma membrane in insulin-secreting MIN6 cells, and Rim2 and Piccolo directly bind to the alpha1.2 subunit of L-type voltage-dependent Ca2+ channels.\",\n      \"method\": \"Co-immunoprecipitation, subcellular localization by immunocytochemistry, dominant-negative overexpression\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple binding assays plus localization and functional overexpression experiments, >142 citations\",\n      \"pmids\": [\"14660679\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"cAMP-GEFII mediates GLP-1-stimulated Ca2+ release through ryanodine receptors (RyR) in pancreatic MIN6 beta-cells, leading to mitochondrial ATP synthesis; a dominant-negative form of cAMP-GEFII (G114E, G422D) blocks RyR-mediated mitochondrial [ATP] increases.\",\n      \"method\": \"Dominant-negative cAMP-GEFII mutant overexpression, ryanodine/xestospongin C pharmacological dissection, mitochondrial Ca2+ and ATP imaging\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — dominant-negative mutagenesis with multiple orthogonal measurements, >177 citations\",\n      \"pmids\": [\"12410638\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"cAMP-GEFII (Epac2) is required for the PKA-independent component of cAMP-stimulated exocytosis in pancreatic beta-cells, and SUR1 deficiency eliminates this PKA-independent exocytosis by preventing cAMP-stimulated Cl- influx into granules needed for priming.\",\n      \"method\": \"Antisense oligodeoxynucleotide knockdown, membrane capacitance measurements, SUR1-/- mouse islets, Epac-selective agonist 8CPT-2Me-cAMP\",\n      \"journal\": \"The Journal of general physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — genetic KO plus pharmacological dissection with electrophysiological readout, >212 citations\",\n      \"pmids\": [\"12601083\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"SUR1, cAMP-GEFII, and Piccolo can form a multi-protein complex; cAMP (via 8-bromo-cAMP) inhibits cAMP-GEFII–SUR1 interaction but not the cAMP-GEFII–SUR1 interaction in the presence of ATP; Piccolo interacts with the alpha1.2 subunit of VDCC in a Ca2+-independent manner, integrating ATP, cAMP, and Ca2+ signals at a specialized beta-cell domain.\",\n      \"method\": \"Co-immunoprecipitation with pharmacological treatments (cAMP analogue, ATP)\",\n      \"journal\": \"Diabetes\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — Co-IP with pharmacological manipulation, single lab, extends prior findings\",\n      \"pmids\": [\"15561922\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Epac2/cAMP-GEFII selectively stimulates the linear (ATP-independent, release-ready vesicle) component of Ca2+-dependent exocytosis in mouse pituitary melanotrophs, whereas PKA controls the threshold (ATP-dependent) component; these two pathways are pharmacologically dissociable.\",\n      \"method\": \"Whole-cell patch-clamp membrane capacitance measurements in pituitary tissue slices, Epac-selective agonist 8-pCPT-2Me-cAMP vs. PKA agonist/inhibitors\",\n      \"journal\": \"The Journal of physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — electrophysiological readout with pharmacological dissection, single lab\",\n      \"pmids\": [\"15994184\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Epac2 (RapGEF4) activation by elevated cAMP (via anthrax edema toxin) induces cytoskeletal changes and inhibits chemotaxis in primary human microvascular endothelial cells through downstream Rap1 activation.\",\n      \"method\": \"Adenoviral overexpression of activated Epac/Rap1, pharmacological cAMP elevation, chemotaxis assay, cytoskeletal imaging\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — gain-of-function with defined cellular phenotype, single lab\",\n      \"pmids\": [\"17491018\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Activation of Epac2 in rat cortical neurons induces spine shrinkage, increased spine motility, removal of synaptic GluR2/3-containing AMPA receptors, and depression of excitatory transmission; Epac2 interaction with neuroligin promotes membrane recruitment of Epac2 and enhances its GEF activity; autism-associated missense mutations in EPAC2/RAPGEF4 alter basal and neuroligin-stimulated GEF activity, dendritic Rap signaling, synaptic protein distribution and spine morphology.\",\n      \"method\": \"Pharmacological Epac2 activation, shRNA knockdown, co-immunoprecipitation, GEF activity assay, live imaging, electrophysiology in cultured rat cortical neurons\",\n      \"journal\": \"Nature neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods (GEF assay, electrophysiology, imaging, KD, mutagenesis), strong paper >133 citations\",\n      \"pmids\": [\"19734897\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"The N-terminal cAMP-binding domain A of Epac2A determines its plasma membrane localization in insulin-secreting MIN6 cells; Epac2B (lacking domain A) localizes primarily to cytoplasm and does not potentiate hormone secretion, whereas addition of a membrane-targeting signal to Epac2B restores secretory function.\",\n      \"method\": \"Identification of novel splice variant Epac2B in Epac2 KO mouse study, immunocytochemistry, hormone secretion assays in MIN6 cells with WT and mutant Epac2 constructs\",\n      \"journal\": \"Journal of cellular physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — domain deletion/substitution with both localization and functional readouts, Epac2 KO mice\",\n      \"pmids\": [\"19170062\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"SNAP-25 interacts with both cAMP-GEFII and Rim2, and is required for cAMP-dependent enhancement of the immediately releasable pool of insulin granules via the PKA-independent cAMP-GEFII pathway; truncation of SNAP-25 C-terminus abolishes cAMP potentiation of rapid exocytosis.\",\n      \"method\": \"Capacitance measurements, protein binding assays (pulldown), Western blot, overexpression of truncated SNAP-25 and BoNT/A in INS-1 cells\",\n      \"journal\": \"American journal of physiology. Endocrinology and metabolism\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — binding assay plus electrophysiological functional readout, single lab\",\n      \"pmids\": [\"19509185\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"RAPGEF4 (Epac2) localizes to the midpiece of equine sperm; activation of RAPGEF3/RAPGEF4 with selective agonist 8pCPT induces acrosomal exocytosis in capacitated stallion sperm and prevents capacitation-dependent membrane hyperpolarization, indicating RAPGEF4 regulates membrane potential and acrosomal exocytosis.\",\n      \"method\": \"Indirect immunofluorescence, acrosome reaction assay, membrane potential measurements, pharmacological agonist\",\n      \"journal\": \"Biology of reproduction\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — localization with functional consequence, pharmacological activation, single lab\",\n      \"pmids\": [\"21471298\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Sulfonylureas activate Epac2 (cAMP-GEFII) to stimulate Rap1 signaling, promoting insulin granule exocytosis in a mechanism distinct from KATP channel closure; gliclazide is unique among sulfonylureas in that it does not activate Epac2, explaining its different secretory profile.\",\n      \"method\": \"Pharmacological studies comparing sulfonylurea effects on Epac2/Rap1 signaling and insulin secretion; mechanistic review integrating prior biochemical findings\",\n      \"journal\": \"Diabetes, obesity & metabolism\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — pharmacological evidence with mechanistic interpretation; supported by prior mechanistic work\",\n      \"pmids\": [\"22118705\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"GLP-1R activation promotes Epac2 (RAPGEF4) translocation to the membrane in cardiomyocytes, and Epac2 deficiency eliminates GLP-1R-dependent stimulation of atrial natriuretic peptide (ANP) secretion, placing Epac2 as a required mediator in the gut-heart GLP-1R–ANP axis regulating blood pressure.\",\n      \"method\": \"Genetic KO of Epac2 (Rapgef4-/-) mice, live cell imaging of Epac2 translocation, ANP secretion assays, blood pressure measurement, aortic ring relaxation assay\",\n      \"journal\": \"Nature medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — genetic KO with specific phenotypic readout plus live imaging of translocation, highly cited >410 citations\",\n      \"pmids\": [\"23542788\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Rapgef4-dependent signaling downstream of Gnas/cAMP elevation regulates proximal tubular exo- and endocytosis in Xenopus pronephros and in human proximal tubular cells; a Rapgef4-specific agonist mimics cholera toxin effects on albumin uptake and secretion.\",\n      \"method\": \"Antisense morpholino knockdown in Xenopus, pharmacological agonist treatment, FITC-albumin uptake/secretion assay in human proximal tubular cell line\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — morpholino KD with phenotypic readout plus pharmacological agonist confirmation in human cells\",\n      \"pmids\": [\"23352791\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"EPAC2 regulates calreticulin (CALR) expression in human endometrial glandular cells, and the EPAC2–CALR signaling axis is required for cAMP-stimulated expression of LIF and COX2/PTGS2 and prostaglandin E2 secretion; EPAC2 or CALR knockdown increases cellular senescence markers.\",\n      \"method\": \"siRNA knockdown of EPAC2 and CALR in EM1 cells, EPAC-selective vs. PKA-selective cAMP analogues, gene expression and PGE2 secretion assays, senescence assay\",\n      \"journal\": \"Journal of molecular endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — siRNA KD with pharmacological dissection and multiple functional readouts, single lab\",\n      \"pmids\": [\"25378661\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Crystallographic analyses reveal that activation of Epac2 by cAMP is accompanied by dynamic structural changes; Epac2 functions as a direct cAMP sensor that activates Rap GTPases via its GEF domain, with distinct structural domains (N-terminal cAMP-binding domain A, DEP domain, and catalytic GEF domain) each contributing to regulation and localization.\",\n      \"method\": \"Crystallographic structural analysis, domain function review integrating published structural and biochemical data\",\n      \"journal\": \"Gene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystallographic structural data plus integration of biochemical domain function studies\",\n      \"pmids\": [\"26390815\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Epac2/Rapgef4 (via PACAP-PAC1 receptor-AC6 pathway) acts as a cAMP sensor downstream of a specific adenylate cyclase isoform (AC6 but not AC7) in neuroendocrine PC12 cells, phosphorylating p38 as a downstream target; this signaling is disrupted by membrane cholesterol depletion.\",\n      \"method\": \"Lentiviral shRNA knockdown of AC6 or AC7, PACAP stimulation, phospho-p38 readout, methyl-β-cyclodextrin cholesterol depletion\",\n      \"journal\": \"Molecular pharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — specific AC isoform KD with defined downstream readout, single lab\",\n      \"pmids\": [\"25769305\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Epac2 knockout (Epac2-/-) mice exhibit anxiety, depression, and hippocampal neurogenesis defects; fluoxetine (SSRI/Prozac) treatment rescues open-field behavior and hippocampal cell proliferation in Epac2-/- mice, implicating Epac2 in serotonin/cAMP-mediated mood regulation and neurogenesis.\",\n      \"method\": \"Genetic KO mouse model, behavioral tests, hippocampal cell proliferation assays, SSRI pharmacological rescue\",\n      \"journal\": \"Translational psychiatry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO with multiple behavioral and cellular phenotypic readouts, single lab\",\n      \"pmids\": [\"27598965\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Epac2 (Rap-GEF4) controls fusion pore expansion during insulin exocytosis by acutely recruiting two pore-restricting proteins, amisyn and dynamin-1, to the exocytosis site; cAMP elevation restricts and slows fusion pore expansion and peptide release in a manner dependent on Epac2 (lost in Epac2-/- mice and with pharmacological Epac2 inactivation); GLP-1R agonists and sulfonylureas activate this pathway.\",\n      \"method\": \"Live-cell TIRF imaging, Epac2-/- mice, pharmacological Epac2 inhibition/activation, Epac2 overexpression, amperometry/capacitance measurements\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — genetic KO plus pharmacology plus live imaging plus overexpression with multiple orthogonal functional readouts\",\n      \"pmids\": [\"31099751\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"RAPGEF4/EPAC2 mediates exendin-4 (GLP-1R agonist)-stimulated autophagic flux in pancreatic beta-cells through a Ca2+-PPP3/calcineurin-TFEB axis, independent of AMPK and mTOR; EPAC2 knockdown abolishes exendin-4-induced autophagy and cell survival, and TFEB overexpression mimics EPAC2-dependent cell protection.\",\n      \"method\": \"siRNA knockdown of RAPGEF4, chemical inhibitors, TFEB overexpression, autophagic flux assays, db/db mouse in vivo treatment\",\n      \"journal\": \"Autophagy\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — siRNA KD, pharmacological dissection, genetic rescue, and in vivo validation with multiple orthogonal readouts\",\n      \"pmids\": [\"34338148\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"EPAC2 overexpression inhibits tubulogenesis and endothelial cell migration in Matrigel assays, while EPAC2 knockdown enhances tube formation and cell migration with elongated morphology and filopodia-like protrusions; RAPGEF4 expression increases during Matrigel-driven tubulogenesis, acting as a negative regulator of angiogenic network formation.\",\n      \"method\": \"Microarray, EPAC2 overexpression and siRNA knockdown in HMVECs, Matrigel tube formation assay, migration assay, morphology imaging\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — gain- and loss-of-function with defined cellular phenotypes, single lab\",\n      \"pmids\": [\"34593918\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"RAPGEF4 is required for electrophysiological maturation of prefrontal cortex neurons (resting membrane potential and inward sodium current) in rhesus macaque and human; CHD8 knockdown impairs neuronal maturation by downregulating RAPGEF4, and restoring RAPGEF4 expression rescues electrophysiological maturation in CHD8-deficient neurons.\",\n      \"method\": \"Patch-seq, single-nucleus multiomic analysis, shRNA knockdown of CHD8, RAPGEF4 rescue overexpression in organotypic slices from macaque and human, electrophysiological recordings\",\n      \"journal\": \"Neuron\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — KD plus genetic rescue with defined electrophysiological phenotype in multiple model systems (macaque and human)\",\n      \"pmids\": [\"40398411\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Hepatic EPAC2 (RAPGEF4) knockdown does not affect hepatic amino acid catabolism gene expression, plasma amino acid levels, or pancreatic alpha-cell hyperplasia, distinguishing EPAC2 from the hepatic GCGR-GNAS-PKA pathway that mediates these effects in the liver-alpha-cell loop.\",\n      \"method\": \"In vivo hepatic knockdown of GCGR, GNAS, PKA, and EPAC2 in mice; measurement of amino acid catabolism genes, plasma amino acids, alpha-cell mass\",\n      \"journal\": \"Diabetes\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis by specific knockdown, comparison of multiple pathway components, defined phenotypic readouts\",\n      \"pmids\": [\"40095004\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Rapgef4 (Epac2) is among 184 genes concordantly dysregulated in both excitatory and inhibitory cortical neurons of Fmr1 KO (Fragile X) mice, is an FMRP target and ASD risk gene; pharmacological antagonism of EPAC2 restores cortical circuit function and ameliorates sensory behavioral phenotypes in Fmr1 KO mice.\",\n      \"method\": \"Cell-type specific mRNA sequencing (TRAP-seq), EPAC2 antagonist systemic administration, electrophysiological circuit recordings, behavioral assays in Fmr1 KO mice\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — transcriptomics plus pharmacological intervention with circuit and behavioral phenotypic readouts; preprint\",\n      \"pmids\": [\"bio_10.1101_2025.04.21.649817\"],\n      \"is_preprint\": true\n    }\n  ],\n  \"current_model\": \"RAPGEF4 (Epac2/cAMP-GEFII) is a direct cAMP sensor that, upon cAMP binding to its N-terminal regulatory domain, undergoes conformational activation and translocates to the plasma membrane where it acts as a guanine nucleotide exchange factor (GEF) for the small GTPase Rap1/Rap2; it forms multi-protein complexes with Rim2, Piccolo, SUR1, SNAP-25, and L-type Ca2+ channels to mediate PKA-independent, Ca2+-dependent exocytosis of insulin and other hormones, controls fusion pore expansion by recruiting amisyn and dynamin-1, regulates synaptic spine remodeling and AMPA receptor trafficking via neuroligin-stimulated GEF activity, drives autophagy in beta-cells through a Ca2+-calcineurin-TFEB axis, and is required for electrophysiological maturation of prefrontal cortex neurons.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"RAPGEF4 (Epac2/cAMP-GEFII) is a cAMP-activated guanine nucleotide exchange factor for Rap1/Rap2 GTPases that functions as a PKA-independent cAMP sensor mediating regulated exocytosis, synaptic remodeling, autophagy, and neuronal maturation. Upon cAMP binding to its N-terminal regulatory domain, Epac2 undergoes conformational activation and translocates to the plasma membrane, where it assembles multi-protein complexes with Rim2, Piccolo, SUR1, SNAP-25, and L-type Ca²⁺ channels to drive Ca²⁺-dependent insulin granule exocytosis and control fusion pore dynamics through recruitment of amisyn and dynamin-1 [PMID:11056535, PMID:12401793, PMID:14660679, PMID:31099751]. In neurons, Epac2 interacts with neuroligin to regulate dendritic spine morphology, AMPA receptor trafficking, and excitatory transmission, and is required for electrophysiological maturation of prefrontal cortex neurons downstream of CHD8 [PMID:19734897, PMID:40398411]. Epac2 also mediates GLP-1 receptor-stimulated atrial natriuretic peptide secretion in cardiomyocytes and drives protective autophagy in pancreatic beta-cells through a Ca²⁺–calcineurin–TFEB axis [PMID:23542788, PMID:34338148].\",\n  \"teleology\": [\n    {\n      \"year\": 2000,\n      \"claim\": \"Identification of RAPGEF4 as a direct cAMP effector in exocytosis resolved how cAMP potentiates secretion independently of PKA, establishing the Epac2–Rim2 interaction as the molecular link between cAMP sensing and the exocytotic machinery.\",\n      \"evidence\": \"Co-immunoprecipitation, pulldown, and reconstituted exocytosis assay with PKA inhibitor\",\n      \"pmids\": [\"11056535\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of Epac2–Rim2 interaction not resolved\", \"Relative contribution of Epac2 versus PKA in vivo not quantified\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Demonstration that the Epac2–Rim2 pathway is essential for incretin-potentiated insulin secretion in native beta-cells moved the mechanism from reconstituted systems to physiological insulin release, answering whether this pathway operates in primary endocrine tissue.\",\n      \"evidence\": \"Antisense knockdown in isolated islets with PKA inhibitor H-89, insulin secretion measurement\",\n      \"pmids\": [\"11598134\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No genetic knockout confirmation at this stage\", \"Downstream effectors beyond Rim2 unknown\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Discovery that Piccolo serves as a Ca²⁺ sensor within the cAMP-GEFII·Rim2·Piccolo complex explained how calcium dependence is integrated into the PKA-independent exocytotic pathway.\",\n      \"evidence\": \"Co-immunoprecipitation, pulldown, antisense knockdown, insulin secretion assay in beta-cells\",\n      \"pmids\": [\"12401793\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stoichiometry and assembly order of the ternary complex unknown\", \"Whether other Ca²⁺ sensors substitute in non-beta-cell contexts untested\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Mapping the interaction of Epac2 with SUR1 (via NBF1) and the connection of Rim2/Piccolo to L-type Ca²⁺ channels revealed a multi-protein signaling hub integrating KATP channel status, cAMP, and Ca²⁺ influx at the beta-cell plasma membrane.\",\n      \"evidence\": \"Co-immunoprecipitation, immunocytochemistry, dominant-negative overexpression in MIN6 cells; SUR1-/- mouse electrophysiology\",\n      \"pmids\": [\"14660679\", \"12601083\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct structural interface between SUR1 and Epac2 unresolved\", \"Whether SUR1 interaction is permissive or instructive for GEF activity unclear\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Showing that Epac2 mediates GLP-1-stimulated Ca²⁺ release through ryanodine receptors linked Epac2 to intracellular Ca²⁺ store mobilization and mitochondrial ATP production, broadening its role beyond plasma membrane exocytosis.\",\n      \"evidence\": \"Dominant-negative Epac2 mutant, pharmacological dissection with ryanodine/xestospongin C, mitochondrial Ca²⁺/ATP imaging in MIN6 cells\",\n      \"pmids\": [\"12410638\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether Epac2 directly activates RyR or acts through Rap-dependent intermediaries unknown\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Discovery that Epac2 interacts with neuroligin and regulates spine morphology, AMPA receptor trafficking, and excitatory synaptic transmission established a neuronal function for Epac2 beyond endocrine exocytosis, and linked autism-associated RAPGEF4 missense variants to altered GEF activity and dendritic signaling.\",\n      \"evidence\": \"Pharmacological activation, shRNA knockdown, co-immunoprecipitation, GEF assay, electrophysiology, and live imaging in cultured rat cortical neurons\",\n      \"pmids\": [\"19734897\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo validation of autism-associated variants lacking\", \"Downstream Rap effectors mediating spine remodeling not identified\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Defining that the N-terminal cAMP-binding domain A governs Epac2 plasma membrane localization and is required for secretory potentiation clarified why the Epac2B splice variant (lacking domain A) is functionally impaired, resolving isoform-specific differences in secretory function.\",\n      \"evidence\": \"Epac2 KO mouse, domain deletion/membrane-targeting rescue constructs, immunocytochemistry and secretion assays in MIN6 cells\",\n      \"pmids\": [\"19170062\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Binding partner for domain A at the membrane not identified\", \"Tissue-specific expression patterns of Epac2A vs Epac2B incompletely mapped\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Genetic knockout of Epac2 in mice eliminated GLP-1R-dependent ANP secretion from cardiomyocytes, establishing Epac2 as an essential mediator in a gut–heart endocrine axis controlling blood pressure.\",\n      \"evidence\": \"Rapgef4-/- mice, live-cell imaging of Epac2 translocation, ANP secretion assays, blood pressure measurement, aortic ring relaxation\",\n      \"pmids\": [\"23542788\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether Epac2 acts through Rap1 or an alternative effector in cardiomyocytes unknown\", \"Human cardiovascular relevance not directly tested\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Crystallographic resolution of Epac2 structural dynamics upon cAMP binding provided a molecular framework for how autoinhibition is relieved and the GEF domain becomes catalytically competent, answering how cAMP binding is mechanically transduced to Rap activation.\",\n      \"evidence\": \"Crystallographic structural analysis integrated with biochemical domain studies\",\n      \"pmids\": [\"26390815\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full-length Epac2 structure in complex with Rap and membrane lipids not determined\", \"Allosteric coupling between the two cAMP-binding domains structurally unresolved\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Demonstration that Epac2 controls fusion pore expansion by recruiting amisyn and dynamin-1 resolved the long-standing question of how cAMP modulates the kinetics (not just competence) of exocytosis, shifting understanding from granule priming to pore regulation.\",\n      \"evidence\": \"TIRF imaging, Epac2-/- mice, pharmacological inhibition/activation, amperometry/capacitance in beta-cells\",\n      \"pmids\": [\"31099751\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct GEF-dependent versus GEF-independent mechanism for amisyn/dynamin-1 recruitment not distinguished\", \"Whether this pore regulation mechanism operates in neurons unknown\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Identification of Epac2 as a mediator of GLP-1R agonist-stimulated autophagy via Ca²⁺–calcineurin–TFEB revealed an entirely new cellular process controlled by Epac2 in beta-cells, distinct from its exocytotic role, answering how incretin signaling promotes beta-cell survival.\",\n      \"evidence\": \"siRNA knockdown, chemical inhibitors, TFEB overexpression rescue, autophagic flux assays, db/db mouse in vivo treatment\",\n      \"pmids\": [\"34338148\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether Epac2-driven autophagy operates in non-beta-cell tissues untested\", \"Specific Rap effector downstream of Epac2 in autophagy induction unidentified\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Rescue of electrophysiological maturation deficits in CHD8-deficient prefrontal cortex neurons by RAPGEF4 re-expression established Epac2 as a critical downstream target of CHD8 for neuronal functional maturation, connecting an autism risk chromatin remodeler to cAMP–Rap signaling.\",\n      \"evidence\": \"Patch-seq, single-nucleus multiomic analysis, shRNA knockdown of CHD8, RAPGEF4 rescue overexpression in organotypic macaque and human cortical slices\",\n      \"pmids\": [\"40398411\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether CHD8 directly regulates RAPGEF4 transcription or acts indirectly unresolved\", \"Downstream Rap effectors mediating neuronal maturation not identified\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the identity of the Rap effectors mediating Epac2-dependent spine remodeling and neuronal maturation, whether fusion pore regulation by amisyn/dynamin-1 recruitment is GEF-dependent, the full-length membrane-associated Epac2 structure, and whether Epac2-driven autophagy generalizes beyond beta-cells.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Rap effectors downstream of Epac2 in neuronal contexts unidentified\", \"Structural basis of Epac2 interaction with neuroligin and amisyn unknown\", \"In vivo validation of autism-associated RAPGEF4 variants in animal models lacking\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 2, 10, 18]},\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [0, 5, 18, 19]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [4, 11, 15]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [11]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0005794\", \"supporting_discovery_ids\": []},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 5, 9, 10, 15, 19]},\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [22]},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [10, 20, 24]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [1, 6, 21]}\n    ],\n    \"complexes\": [\n      \"Epac2–Rim2–Piccolo\",\n      \"Epac2–SUR1–Rim2\"\n    ],\n    \"partners\": [\n      \"RIMS2\",\n      \"PCLO\",\n      \"ABCC8\",\n      \"SNAP25\",\n      \"NLGN1\",\n      \"AMISYN\",\n      \"DNM1\",\n      \"CHD8\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}